MedTate is a privately-owned British nutraceutical company based in Mayfair, London. Founded in 2011 by Pete Tate, the company draws inspiration from his grandfather, LK Tate, who combat diabetes with traditional Indian Ayurvedic herbs and lived a healthy life until he was 100. MedTate delivers clinically validated wellness supplements and is dedicated to research and development in the health care, manufacturing, and pharmaceutical industries.
The company believes in the constant evolution of healthcare and conducts extensive scientific research to produce innovative and useful products. With a focus on quality control at all stages of development, MedTate aims to deliver the highest quality products to its customers. The ingredients used are carefully selected based on systematic research work and are sourced from natural environments free from pollution and GMOs. MedTate comprises two business divisions: MedCare™ (Nutraceuticals) and MedCure™ (Biotechnology), both independently operating while sharing data from their R&D processes.
While there is no information available about their last investment and investors, MedTate's commitment to quality, innovation, and natural ingredients positions it at the nexus of health and wellness in the United Kingdom's healthcare sector.
There is no investment information
No recent news or press coverage available for MedTate.